β‐amyloid burden is not associated with rates of brain atrophy
- 27 February 2008
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 63 (2) , 204-212
- https://doi.org/10.1002/ana.21223
Abstract
Objective To test the hypothesis that β‐amyloid (Aβ) burden is associated with rates of brain atrophy. Methods Forty‐five subjects who had been prospectively studied, died, and had an autopsy diagnosis of low, intermediate, or high probability of Alzheimer's disease who had two volumetric head magnetic resonance imaging scans were identified. Compact and total (compact + diffuse) Aβ burden was measured using a computerized image analyzer with software program to detect the proportion of gray matter occupied by Aβ. Visual ratings of Aβ burden were also performed. The boundary shift integral was used to calculate change over time in whole‐brain and ventricular volume. All boundary shift integral results were annualized by adjusting for scan interval. Demographics, cognitive measures, clinical diagnoses, apolipoprotein E genotype, neurofibrillary tangle (NFT) pathology, and vascular lesion burden were determined. Results There was no correlation between compact or total Aβ burden, or visual Aβ ratings, and rates of brain loss or ventricular expansion in all subjects. However, significant correlations were observed between rates of brain loss and age, Braak NFT stage, and change over time in cognitive measures. These features also correlated with rates of ventricular expansion. The rates of brain loss and ventricular expansion were greater in demented compared with nondemented subjects. Interpretation These findings suggest that rate of brain volume loss is not determined by the amount of insoluble Aβ in the gray matter. Ann Neurol 2007Keywords
This publication has 51 references indexed in Scilit:
- Rates of cerebral atrophy differ in different degenerative pathologiesBrain, 2006
- Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography studyAnnals of Neurology, 2006
- A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CTStroke, 2001
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- The Neuropathological Diagnosis of Alzheimer’s Disease: Clinical-Pathological StudiesNeurobiology of Aging, 1997
- A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imagingPublished by Elsevier ,1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- ALZHEIMER'S DISEASE AND TAU PROTEINSThe Lancet, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982